Antibody mediated rejection (AMR) is associated with a variety of graft-reactive antibodies following kidney transplant. To characterize these antibodies, we immortalized 107 B cell clones from a patient with AMR. In a previous study, we showed that six clones were reacting to multiple self-antigens as well as to HLA and MICA for two of them, thus displaying a pattern of polyreactivity. We show here that all six polyreactive clones also reacted to apoptotic but not viable cells. More generally we observed a nearly perfect overlap between polyreactivity and reactivity to apoptotic cells. Functionally, polyreactive antibodies can activate complement, resulting in the deposition of C3d and C4d at the surface of target cells. Testing the serum of 88 kidney transplant recipients revealed a significantly higher IgG reactivity to apoptotic cells in AMR patients than in patients with stable graft function. Moreover, total IgG purified from AMR patients had increased complement activating properties compared to IgG from non-AMR patients. Overall, our studies show the development of polyreactive antibodies cross-reactive to apoptotic cells during AMR. Further studies are now warranted to determine their contribution to the detection of C4d in graft biopsies as well as their role in the pathophysiology of AMR. The authors show that antibody-mediated rejection is accompanied by the development of serum polyreactive antibodies that bind apoptotic cells and activate complement, potentially triggering C4d deposition in damaged graft tissues. © 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement / Porcheray, F.; Fraser, J. W.; Gao, B.; Mccoll, A.; Devito, J.; Dargon, I.; Helou, Y.; Wong, W.; Girouard, T. C.; Saidman, S. L.; Colvin, R. B.; Palmisano, A.; Maggiore, U.; Vaglio, A.; Smith, R. N.; Zorn, E.. - In: AMERICAN JOURNAL OF TRANSPLANTATION. - ISSN 1600-6135. - 13:10(2013), pp. 2590-2600. [10.1111/ajt.12394]

Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement

Maggiore, U.;Vaglio, A.;
2013

Abstract

Antibody mediated rejection (AMR) is associated with a variety of graft-reactive antibodies following kidney transplant. To characterize these antibodies, we immortalized 107 B cell clones from a patient with AMR. In a previous study, we showed that six clones were reacting to multiple self-antigens as well as to HLA and MICA for two of them, thus displaying a pattern of polyreactivity. We show here that all six polyreactive clones also reacted to apoptotic but not viable cells. More generally we observed a nearly perfect overlap between polyreactivity and reactivity to apoptotic cells. Functionally, polyreactive antibodies can activate complement, resulting in the deposition of C3d and C4d at the surface of target cells. Testing the serum of 88 kidney transplant recipients revealed a significantly higher IgG reactivity to apoptotic cells in AMR patients than in patients with stable graft function. Moreover, total IgG purified from AMR patients had increased complement activating properties compared to IgG from non-AMR patients. Overall, our studies show the development of polyreactive antibodies cross-reactive to apoptotic cells during AMR. Further studies are now warranted to determine their contribution to the detection of C4d in graft biopsies as well as their role in the pathophysiology of AMR. The authors show that antibody-mediated rejection is accompanied by the development of serum polyreactive antibodies that bind apoptotic cells and activate complement, potentially triggering C4d deposition in damaged graft tissues. © 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.
Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement / Porcheray, F.; Fraser, J. W.; Gao, B.; Mccoll, A.; Devito, J.; Dargon, I.; Helou, Y.; Wong, W.; Girouard, T. C.; Saidman, S. L.; Colvin, R. B.; Palmisano, A.; Maggiore, U.; Vaglio, A.; Smith, R. N.; Zorn, E.. - In: AMERICAN JOURNAL OF TRANSPLANTATION. - ISSN 1600-6135. - 13:10(2013), pp. 2590-2600. [10.1111/ajt.12394]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11381/2856115
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 44
social impact